Case report: Pathologic long bone fracture in a patient with systemic mastocytosis

Clinical Orthopaedics and Related Research

Volumn 459, Issue , 2007, Pages 263-269

  King, Joseph J ^a   Crawford, Eileen A ^b   Iwenofu, O Hans ^c   Fox, Edward J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; HYDROXYUREA; IMATINIB; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PANTOPRAZOLE;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMPRESSION FRACTURE; DISEASE COURSE; DYSPEPSIA; FALLING; FEMUR INTERTROCHANTERIC FRACTURE; HUMAN; HUMAN TISSUE; INTRAMEDULLARY NAILING; MALE; PATHOLOGIC FRACTURE; POOR GENERAL CONDITION; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC MASTOCYTOSIS; VERTEBRAL CANAL STENOSIS; FEMUR FRACTURE; MIDDLE AGED;

FEMORAL FRACTURES; HUMANS; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED;

EID: 34249949156     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e3180487ced     Document Type: Article

References (46)

1. Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med. 2004;55:419-432.
2. Andrew SM, Freemont AJ. Skeletal mastocytosis. J Clin Pathol. 1993;46:1033-1035.
3. Anonymous. Osteopenia. Am J Med. 1980;69:915-922.
4. Arias M, Villalba C, Requena I, Vazquez-Veiga H, Sesar A, Pereiro I. Acute spinal epidural hematoma and systemic mastocytosis. Spine. 2004;29:E161-E163.
5. Barer M, Peterson LF, Dahlin DC, Winkelmann RK, Stewart JR. Mastocytosis with osseous lesions resembling metastatic malignant lesions in bone. J Bone Joint Surg Am. 1968;50:142-152.
6. Bendel WL Jr, Race GJ. Urticaria pigmentosa with bone involvement. J Bone Joint Surg Am. 1963;45:1043-1056.
7. Brumsen C, Hamdy NA, Papapoulos SE. Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy. J Bone Miner Res. 2002;17:567-569.
8. Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM, Hamdy NA. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone. 2002;31:556-561.
9. Brunning RD, McKenna RW, Rosai J, Parkin JL, Risdall R. Systemic mastocytosis: extracutaneous manifestations. Am J Surg Pathol. 1983;7:425-438.
10. Castling B, Smith AT, Myers B. Involvement of the jaw bones in systemic mastocytosis. Br J Oral Maxillofac Surg. 2006;44:87-88.
11. Chines A, Pacifici R, Avioli LV, Teitelbaum SL, Korenblat PE. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab. 1991;72:140-144.
12. Cryer PE, Kissane JM. Systemic mastocytosis. Am J Med. 1976;61:671-680.
13. de Gennes C, Kuntz D, de Vernejoul MC. Bone mastocytosis: a report of nine cases with a bone histomorphometric study. Clin Orthop Relat Res. 1992;279:281-291.
14. Fallon MD, Whyte MP, Craig RB Jr, Teitelbaum SL. Mast-cell proliferation in postmenopausal osteoporosis. Calcif Tissue Int. 1983;35:29-31.
15. Fallon MD, Whyte MP, Teitelbaum SL. Systemic mastocytosis associated with generalized osteopenia: histopathological characterization of the skeletal lesion using undecalcified bone from two patients. Hum Pathol. 1981;12:813-820.
16. Frame B, Nixon RK. Bone-marrow mast cells in osteoporosis of aging. N Engl J Med. 1968;279:626-630.
17. Golkar L, Bernhard JD. Mastocytosis. Lancet. 1997;349:1379-1385.
18. Grieser T, Minne HW. Systemic mastocytosis and skeletal lesions. Lancet. 1997;350:1103-1104.
19. Harrison BD, Ashford RA, Hatton CS. Systemic mastocytosis: a case treated with interferon alpha and radiotherapy. Clin Lab Haematol. 1994;16:291-294.
20. Harvey JA, Anderson HC, Borek D, Morris D, Lukert BP. Osteoporosis associated with mastocytosis confined to bone: report of two cases. Bone. 1989;10:237-241.
21. Havard CW, Scott RB. Urticaria pigmentosa with visceral and skeletal lesions. Q J Med. 1959;28:459-470.
22. Hills E, Dunstan CR, Evans RA. Bone metabolism in systemic mastocytosis: a case report. J Bone Joint Surg Am. 1981;63:665-669.
23. Huang TY, Yam LT, Li CY. Radiological features of systemic mast-cell disease. Br J Radiol. 1987;60:765-770.
24. Inaoui R, Petit B, Jaccard A, Bertin P, Treves R. Aggressive systemic mastocytosis. Joint Bone Spine. 2003;70:64-66.
25. Ispas L, Henriksen RA, Metzger WJ. The many faces of systemic mastocytosis. Ann Allergy Asthma Immunol. 2001;87:6-14; quiz 15, 67.
26. Johnstone PA, Mican JM, Metcalfe DD, DeLaney TF. Radiotherapy of refractory bone pain due to systemic mast cell disease. Am J Clin Oncol. 1994;17:328-330.
27. Lehmann T, Beyeler C, Lammle B, Hunziker T, Vock P, Olah AJ, Dahinden C, Gerber NJ. Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. Br J Rheumatol. 1996;35:898-900.
28. Lim AY, Ostor AJ, Love S, Crisp AJ. Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis. 2005;64:965-966.
29. Lombardi LJ, Cleri DJ, Present DA, Vernaleo JR, Epstein EM. Systemic mastocytosis with pathologic fractures of distal long bones. Orthopedics. 1993;16:320-324.
30. Marshall A, Kavanagh RT, Crisp AJ. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol. 1997;36:393-396.
31. Martinez AE, Medina AM, Hyde JA, Krill-Jackson E, Blaustein A, Schwartz M, Cabello-Inchausti B. The faces of mast cell disease: bone marrow infiltrates in 3 patients with systemic mastocytosis. Ann Diagn Pathol. 2005;9:81-85.
32. McKenna MJ, Frame B. The mast cell and bone. Clin Orthop Relat Res. 1985;200:226-233.
33. Moret H, Plihal E, Saudan Y. Case report of bone mastocytosis: total hip arthroplasty for osteoarthritis and open reduction for condylar fracture of the knee. Clin Rheumatol. 1994;13:619-623.
34. Pardanani A. Systemic mastocytosis: bone marrow pathology, classification, and current therapies. Acta Haematol. 2005;114:41-51.
35. Rafii M, Firooznia H, Golimbu C, Balthazar E. Pathologic fracture in systemic mastocytosis: radiographic spectrum and review of the literature. Clin Orthop Relat Res. 1983;180:260-267.
36. Sagher F, Cohen C, Schorr S. Concomitant bone changes in urticaria pigmentosa. J Invest Dermatol. 1952;18:425-432.
37. Sagher F, Even-Paz Z. Mastocytosis and the Mast Cell. Chicago, IL: Year Book Medical Publishers; 1967.
38. Siegel S, Sadler MA, Yook C, Chang V, Miller J. Systemic mastocytosis with involvement of the pelvis: a radiographic and clinicopathologic study-a case report. Clin Imaging. 1999;23:245-248.
39. Sostre S, Handler HL. Bony lesions in systemic mastocytosis: scintigraphic evaluation. Arch Dermatol. 1977;113:1245-1247.
40. Tefferi A, Pardanani A. Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep. 2004;3:197-202.
41. Tharp MD. The spectrum of mastocytosis. Am J Med Sci. 1985;289:119-132.
42. Tolar J, Tope WD, Neglia JP. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis. N Engl J Med. 2004;350:735-736.
43. Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine (Baltimore). 1988;67:345-368.
44. Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer. 1988;62:965-972.
45. Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, Bennett JM, Metcalfe DD. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res. 2003;27:635-641.
46. Webb TA, Li CY, Yam LT. Systemic mast cell disease: a clinical and hematopathologic study of 26 cases. Cancer. 1982;49:927-938.